31 Oct, 2024 Medicines Australia Code of Conduct – New Edition Released By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Hazel Pang +1 more... Show less On 30 October 2024, Medicines Australia (MA) formally adopted a new edition (Edition 20) of the MA Code of Conduct (MA Code), which will...
31 May, 2023 Expert witnesses in Australian patent litigation - Recent federal court decisions reinforce the need to choose your expert witnesses carefully By Nicholas Tyacke Robynne Sanders Greg Bodulovic Alexandra de Zwart Jordan Davis +2 more... Show less The role of the expert witness is often crucial in Australian patent litigation, especially where the invention in question is...
16 May, 2023 The future of the assisted reproductive technology (ART): Modernising ART processes with AI By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran +1 more... Show less Assisted fertilisation processes involve striking the perfect balance between a range of complex factors – all of which play a critical...
17 Apr, 2023 ESG Issues: Clinical Trials and Diversity (Racial Bias in Medical Technology) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Abi Ketheeswaran Sharon Zhang +2 more... Show less ESG is increasingly a primary focus for companies and consumers alike. Across all industries, companies are under immense scrutiny from...
17 Apr, 2023 Inspirational Women in Life Sciences: Rebecca Lacey and Sonya Roy By Alexandra de Zwart In the third edition of our Cortex series on Inspirational Women in Life Sciences, we are delighted to feature two incredible Australian...
04 Apr, 2023 You say “ed”, they say “ad”: The fine line between lawful educational campaigns and unlawful advertising of therapeutic goods in Australia By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Companies operating in the life sciences industry play a vital role in raising awareness of diseases and other medical conditions,...
14 Mar, 2023 Advertising therapeutic goods in Australia (don't let your ad make you sad) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...
15 Nov, 2022 Clinical Trials and Privacy Matters: A Cross-border Guide By Marco de Morpurgo This week our Life Sciences team published the first edition of its Cross-border Guide to Clinical Trials and Privacy. The Guide will...
18 Mar, 2022 Clarity and Caution Ahead for Advertisers: Changes to the Australian Therapeutic Goods Advertising Code By Greg Bodulovic Michelle Wang After a lengthy industry consultation process by the Australian Therapeutic Goods Administration, the updated Therapeutic Goods...
17 Oct, 2021 Patent term extensions in Australia – What if the patent covers more than one approved product? By Nicholas Tyacke Alexandra de Zwart In its second significant recent decision addressing patent term extensions in Australia, the Federal Court of Australia, in Merck Sharp...
12 May, 2021 Australian patent box tax incentive announced in Federal Budget By Nicholas Tyacke Alexandra de Zwart Holly Yuan Greg Bodulovic Robynne Sanders +2 more... Show less The 2021-2022 Australian Federal Budget was unveiled last night (11 May 2021). Deemed the ‘COVID-19 Recovery Budget’, it includes a...
13 Apr, 2021 TGA's Consultation on Managing Medicine Shortages By Joanne Lim The Australian Therapeutic Goods Administration (TGA) is currently conducting a public consultation on proposals to help prevent,...
10 Mar, 2021 TGA implements stricter regulation of software-based medical devices By Joanne Lim The Australian Therapeutic Goods Administration (TGA) has implemented reforms to the regulation of software-based medical devices,...
22 Feb, 2021 The Australian PBAC reforms its review process of unimplemented positive recommendations By Nicholas Tyacke Sarah Parkin Joanne Lim The Australian Pharmaceutical Benefits Advisory Committee (PBAC) has amended its process for reviewing positive PBAC recommendations that...
17 Feb, 2021 TGA Consultation on the Repurposing of Prescription Medicines By Joanne Lim The Australian Therapeutic Goods Administration (TGA) is currently conducting a public consultation into the “repurposing” of...